Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Should very low-risk prostate cancer on active surveillance be considered a contraindication to anatomical enucleation? This patient had a >100 cc prostate with severe LUTS and bladder outlet obstruction, and a clear desire to be free from his urinary symptoms and improve his quality of life. We proceeded with...

10,447 görüntüleme • 19 gün önce •via X (Twitter)

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Dr. Abhishek Shukla (Senior Geriatrician) in conversation with Dr. Rohit Kapoor (MCh Urology) a senior urologist, to discuss a very common problem seen in elderly men—weak urine flow, frequent urination, and the feeling of incomplete bladder emptying.” Dr. Abhishek Shukla asked, “Many senior citizens complain that their urinary stream has become weak, urine comes drop by drop or intermittently, and they need to wake up multiple times at night to pass urine. Even after urinating, they feel that the bladder is not empty. What could be the reason?” Dr. Rohit Kapoor explained that these symptoms are most commonly related to the prostate gland. The prostate is a small gland located below the urinary bladder and surrounds the urinary passage (urethra). As men grow older, the prostate often enlarges and can obstruct the urine flow. He explained that this enlargement may be Benign Prostatic Hyperplasia (BPH), which is non-cancerous and very common with aging. In many cases, medicines can effectively control symptoms. However, an important point is that the size of the prostate alone does not decide treatment. A large prostate does not always need surgery if symptoms are controlled with medicines. On the other hand, even a smaller prostate can cause severe blockage and may require surgery if medicines fail. Dr. Kapoor also emphasized the importance of PSA (Prostate-Specific Antigen) testing for men above 50 years of age. Along with ultrasound and uroflowmetry, PSA helps detect prostate cancer early. He advised that every man above 50 should get a PSA test yearly. Dr. Abhishek Shukla concluded by reminding viewers that urinary problems should never be ignored. Early diagnosis and treatment can prevent complications and improve quality of life. Modern treatments, including advanced robotic surgery, now offer safer and highly precise solutions. #UrinaryHealth #Urology #pelvichealth #Incontinence #OveractiveBladder #BladderControl #BPH (Benign Prostatic Hyperplasia) #ProstateHealth #enlargedprostate #urinarytractinfection #uti #bladderhealth #urinarysystem #urology #urinary #urinaryincontinence #womenshealth #healthylifestyle #bladder #urologist

Association of International Doctors. (India).

25,997 görüntüleme • 1 ay önce

In the UK right now, there’s a bid to mandate the ENTIRE population have synthetic folate introduced into their nations food supply. They even want it in wholemeal flour. But this scientist found a 2.6 x increased risk of prostate cancer from increased folic acid. Jeremy Clarkson is campaigning for more screening. That screening might end up doing MORE harm than good. Because the men get tested end up going down the road of standard of care treatments, causing life altering surgery, who would have only died WITH signs of prostate cancer... not FROM it. The quality of life from standard of care is devastating: Dr Clare Craig - “It takes men, who would have died WTIH prostate cancer... without knowing they had prostate cancer... without any horrible interventions and surgery... and puts them through all that... and fails to impact on overall mortality...” “When you have your prostate out, 4 in 5 men will end up impotent.... and 1 in 5 will end up incontinent” Those 2 campaigns working in parallel, become a sort of Double Whammy. A campaign mandating the entire population receive a synthetic product potentially increasing the rate of prostate cancer. The other campaign increasing the people found through screening, leading to life altering standard of care treatments. It reminds me of that study in Sweden, showing more Sun exposure led to women living longer... but they push universal sunscreen use. And those women who lived longer didn’t die from Melanoma even though it was found more. Dr. Claire Craig - “If you are exposed to folic acid... your risk of prostate cancer is more than DOUBLED... If you care about prostate cancer, you need to campaign to get this stuff out of our flour” Jeremy Clarkson (Jeremy Clarkson) needs to watch this.

Humanspective

26,066 görüntüleme • 1 ay önce

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

Camus

31,209 görüntüleme • 8 ay önce

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Camus

38,936 görüntüleme • 11 ay önce

All the tributes I've read about the dearly departed got me thinking about how, a lot of times, we wait until the funeral to give people their flowers... instead of while they are still alive to smell them. So, I want to be intentional about appreciating people who have had a profound influence and impact on my life while they are here. Today, I want to celebrate one of my mentors, Egbon Leke Alder. I'm a fiend for wisdom, and you would be hard pressed to find a mind wiser than his on this planet. My wife and I are convinced that he uses more of his brain power than most human beings. His intelligence is divine, his creativity is sublime, and his kindness? Truly, one of a kind. He is a genius in every sense of the word. When we were planning our campaign, I knew I had to "sit at his feet." I had no idea he was battling illness because he always found time to meet with my team and I repeatedly. He gave us counsel, strategy, and wisdom - the kind that even if you could put a price on it, we could never afford to pay. I didn't end up winning the election, but spending quality time with one of the greatest minds in Nigerian history? That's a win every single time and a personal highlight in my life. Egbon, I can offer you nothing but the prayers of a grateful heart. May God continue to prosper, protect, and preserve you. May He give you the desires of your heart and reward you for me. May the rest of your years be the best of them, and may the peace that passes all understanding guard your heart and mind in Christ Jesus. Thank you for believing in me, Sir. I hope to one day repay your faith by what I do and who I become, by the grace of God. Also, please buy his book.

Banky Wellington

104,352 görüntüleme • 2 yıl önce

Fenbendazole & Cancer Remission: The Peer-Reviewed Cases Challenging Modern Oncology A peer-reviewed medical publication has delivered a bombshell that the mainstream oncology world cannot ignore. It documents three cases of patients with advanced, metastatic cancer who achieved remarkable remissions after a radical course of action: self-medicating with veterinary-grade medication. The paper details three individuals who were essentially out of conventional options: ➡️ Case 1: An 83-year-old woman with stage 4 breast cancer that had spread to her liver, lungs, and bones. After refusing chemotherapy and entering hospice care, she began a regimen of fenbendazole (a dewormer for dogs), Vitamin D, and multivitamins. By June 2022, her cancer was in complete remission. She has been cancer-free for over three years. ➡️ Case 2: A man with stage 4 prostate cancer and extensive bone metastases. While on standard hormone therapy, he added high-dose fenbendazole and a cocktail of supplements (Vitamin K2, magnesium, melatonin, curcumin). The result? Within 26 months, his cancer growth and spread had completely halted. ➡️ Case 3: A man in his 60s with advanced melanoma, slated for immunotherapy. While waiting for treatment, he began the same fenbendazole and vitamin protocol. By February 2024, before even starting the planned drug, his cancer had completely disappeared. The Critical Nuance Everyone Must Understand: The authors of this paper are NOT advocating for patients to self-medicate with veterinary drugs. The purpose of publishing these cases is precisely the opposite: to sound an alarm. When patients in desperate situations feel compelled to turn to clandestine, unapproved treatments, it is a clear sign that current options are failing them. This paper uses these dramatic "success stories" as a powerful call to action for the scientific community to launch proper clinical trials. The central question is no longer just if cancer metabolism can be targeted, but how we can safely and effectively harness these pathways. The combination of a repurposed drug with foundational lifestyle and nutritional support (the common denominator in all three cases) presents a compelling, albeit unorthodox, avenue for research. This is where the conversation about medical freedom, patient desperation, and scientific rigor collides. It underscores an urgent need to explore all promising pathways, especially those that are patient-driven, with the rigor they deserve. What are your thoughts on the role of repurposed drugs in modern oncology?

Camus

50,224 görüntüleme • 8 ay önce

A stunning account from Dr. Patrick Soon-Shiong reveals a catastrophic failure at the FDA, where bureaucratic indifference and potential conflicts of interest are blocking a groundbreaking cancer treatment. His drug, already approved for a form of bladder cancer, is a unique natural protein therapy that activates the body's own immune system (natural killer cells, T-cells). It has shown remarkable long-term results, preserving patients' bladders for over a decade and avoiding radical, high-mortality surgery. Yet, when seeking a simple label expansion for another bladder cancer indication—a logical step—the FDA "Refused to File." In a desperate meeting, Dr. Soon-Shiong confronted two senior reviewers. He posed a heartfelt question: If his own father had bladder cancer, and this safe, approved drug could save his bladder, why wouldn't they give him that chance? Their chilling response: "I don't care." Pushed for rationale, they fell back on outdated dogma: "This is how we've done it for years." They demanded a comparative trial against chemotherapy, which he argued is unethical. Chemotherapy destroys immune memory and carries severe risks, while his treatment offers durable freedom. Weeks later, the hypocrisy was exposed. Johnson & Johnson received a "Priority Review" for a bladder cancer chemotherapy—a treatment with a 1% mortality rate and a 24% rate of devastating low lymphocyte counts. Why the discrepancy? Dr. Soon-Shiong’s drug, despite its breakthrough status, was denied the same priority. This begs the question: Is the "revolving door" between the FDA and Big Pharma putting corporate profits over patient lives? Even with well-intentioned leaders like Bobby Kennedy and Dr. Marty Makary, the entrenched bureaucracy seems immune to both scientific evidence and human compassion. Patients are being left behind, and innovators are being stiff-armed, all while the old, toxic guard is given the red-carpet treatment. This is more than a story of one drug; it's a systemic crisis in American medicine.

Camus

188,269 görüntüleme • 10 ay önce

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

405,353 görüntüleme • 1 yıl önce

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

1,478,036 görüntüleme • 1 yıl önce

Donald Trump on why he didn't want to be President in 1980: In a fascinating interview with Rona Barrett, a 34-year-old Donald Trump is asked if he would ever want to be President of the United States. His answer might surprise you: "I really don't believe I would, Rona. But I would like to see somebody as the president who could do the job." Trump explains why the most capable people stay away from politics: "Most men are frightened of politics today… The most capable people are not necessarily running for political office and that is a very sad commentary on the country. They head major corporations and they had this and that, but they are not running for political office." When Barrett pushes him on why he himself wouldn't run, given his wealth and accomplishments, Trump gives a revealing answer: "Because I think it's a very mean life. I would love and I would dedicate my life to this country, but I see it as being a mean life." He continues with a critique of the political process itself: "Somebody with wrong views and somebody with the kind of views that are maybe a little bit unpopular, which may be right but may be unpopular... wouldn't necessarily have a chance of getting elected against somebody with no great brain but a big smile. And that's a sad commentary for the political process." Trump points to television as the culprit, using a striking historical example: "The Abraham Lincolns of the world... Abraham Lincoln would probably not be electable today because of television. He was not a handsome man and he did not smile at all. He would not be considered to be a prime candidate for the presidency and that's a shame, isn't it?" Despite his reluctance to run himself, Trump expresses a strong belief in the power of the right leader: "There is one man that can turn this country around. I could tell you I know a number of people that would be excellent presidents… they're very, very competent, they're leaders, they have the respect of everybody, and they would be fabulous presidents. But they're not running for political office." What Trump said he'd rather do at the time: "What I would like to be involved in is trying to help choose somebody or working with a group of people whereby they put up a candidate who would be acceptable to be the president of the country."

History Nerd

217,768 görüntüleme • 3 ay önce

RFK Jr. and Dr. Oz just announced they’re working with major insurance companies to eliminate and streamline preauthorizations. RFK shared a story from a physician friend: “A patient from New Jersey suffering from severe heart failure was transferred to New York Presbyterian Hospital for a lifesaving transplant.” “The patient urgently needed a mechanical heart pump, a device essential to sustain their life during the wait.” “The insurance company had approved the heart transplant but then denied authorization for the mechanical heart pump, deeming it unnecessary.” “The decision created a perplexing contradiction. The patient was cleared for a transplant and not for the critical device needed to keep him alive.” “With the patient in the Operating Room and his life at stake, the medical team was faced with a profound ethical challenge.” “Should they adhere to the insurance company's denial, which would likely lead to the patient's death, or take action to save the patient's life knowing it could result in legal or professional consequences.” “The medical team chose to prioritize the patient’s survival in planting the mechanical heart pump.” “This decision allowed the patient to live long enough to receive a successful heart transplant.” “My friend, the doctor, was then sued by the insurance company… That lawsuit was dropped.” “There are many situations in this country where that ethical decision for one reason or another would not have been made, and people lose their lives because of prior authorization.”

End Tribalism in Politics

121,490 görüntüleme • 1 yıl önce

RFK Jr. shared a tragic story that exposes how prior authorization delays can jeopardize lives—even when a patient is moments away from life-saving surgery. “A patient from New Jersey suffering from severe heart failure was transferred to New York Presbyterian Hospital for a lifesaving transplant.” “The patient urgently needed a mechanical heart pump, a device essential to sustain their life during the wait.” “The insurance company had approved the heart transplant but then denied authorization for the mechanical heart pump, deeming it unnecessary.” “The decision created a perplexing contradiction. The patient was cleared for a transplant and not for the critical device needed to keep him alive.” “With the patient in the Operating Room and his life at stake, the medical team was faced with a profound ethical challenge.” “Should they adhere to the insurance company's denial, which would likely lead to the patient's death, or take action to save the patient's life knowing it could result in legal or professional consequences.” “The medical team chose to prioritize the patient’s survival in planting the mechanical heart pump.” “This decision allowed the patient to live long enough to receive a successful heart transplant.” “My friend, the doctor, was then sued by the insurance company… That lawsuit was dropped.” “There are many situations in this country where that ethical decision for one reason or another would not have been made, and people lose their lives because of prior authorization.”

MAHA PAC🗽

26,396 görüntüleme • 1 yıl önce